SERPINE1 |
P05121
|
serpin family E member 1
|
Enzyme modulator
|
4.4E-02 |
0.359 |
0.885 |
71
|
ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
67
|
IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
67
|
NOS2 |
P35228
|
nitric oxide synthase 2
|
|
4.0E-15 |
0.364 |
0.923 |
67
|
FASLG |
P48023
|
Fas ligand
|
Signaling
|
0.18 |
0.430 |
0.885 |
66
|
TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
66
|
EDN1 |
P05305
|
endothelin 1
|
Signaling
|
0.46 |
0.380 |
0.846 |
63
|
GSTM1 |
P09488
|
glutathione S-transferase mu 1
|
|
2.1E-03 |
0.380 |
0.923 |
62
|
VDR |
P11473
|
vitamin D receptor
|
Nuclear receptor
|
1.7E-05 |
0.352 |
0.885 |
61
|
CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
59
|
HIF1A |
Q16665
|
hypoxia inducible factor 1 subunit alpha
|
Transcription factor
|
0.98 |
0.327 |
0.923 |
59
|
GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
55
|
IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |
55
|
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
53
|
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
53
|
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
53
|
HMOX1 |
P09601
|
heme oxygenase 1
|
|
9.7E-03 |
0.381 |
0.923 |
53
|
MBL2 |
P11226
|
mannose binding lectin 2
|
Receptor
|
2.7E-03 |
0.390 |
0.846 |
53
|
TLR2 |
O60603
|
toll like receptor 2
|
|
1.0E-06 |
0.361 |
0.923 |
53
|
MMP3 |
P08254
|
matrix metallopeptidase 3
|
Enzyme
|
5.7E-15 |
0.408 |
0.885 |
52
|
PON1 |
P27169
|
paraoxonase 1
|
|
9.8E-11 |
0.409 |
0.885 |
52
|
BIRC5 |
O15392
|
baculoviral IAP repeat containing 5
|
Enzyme modulator
|
5.6E-02 |
0.495 |
0.731 |
50
|
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
50
|
SPP1 |
P10451
|
secreted phosphoprotein 1
|
|
2.1E-06 |
0.353 |
0.885 |
50
|